Susono, Japan

Syoichi Isami

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2011.


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Syoichi Isami: Advancements in Antitumor Agents

Introduction: Syoichi Isami, an inventive spirit based in Susono, Japan, has made significant contributions to the field of medicinal chemistry through his innovative work on pyrimidine derivatives. With one patent to his name, Isami has laid the groundwork for potential antitumor agents that could make a difference in cancer treatment.

Latest Patents: Isami's notable patent revolves around a pyrimidine derivative compound, providing a unique antitumor agent. The invention highlights a compound represented by a specific formula, which includes various substituents, offering potential for pharmaceutical applications in treating tumors. The details of the patent specify that the active ingredient can exist in various forms, including pharmaceutically acceptable salts, broadening its potential applicability in the medical field.

Career Highlights: Syoichi Isami has been associated with Kyowa Hakko Kirin Co., Limited, a company renowned for its dedication to innovation in biopharmaceuticals. His work at the company is characterized by a strong focus on developing new therapeutic agents, exemplifying his commitment to enhancing healthcare.

Collaborations: Throughout his career, Isami has collaborated with talented professionals such as Hitoshi Arai and Tsutomu Matsumura. These partnerships have fostered a collaborative environment that promotes the sharing of ideas and expertise, ultimately leading to groundbreaking advancements in their respective fields.

Conclusion: Syoichi Isami's contributions to the realm of antitumor agents through his innovative pyrimidine derivative compound patent demonstrate the importance of continued research and development in medicine. His collaboration with esteemed colleagues at Kyowa Hakko Kirin highlights the collective effort required to push the boundaries of scientific discovery, promising a brighter future in cancer treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…